The Potential of SCUBE-1 Levels as an Indicator of Impaired Placental Function in Preeclampsia: A Randomized Clinical Trial
Received: 05 Mar 2024 | Received in revised form: 27 Oct 2024
Accepted: 11 Nov 2024 | Available online: 29 Nov 2024Halil İbrahim ALTINCIa , Neşe YÜCELa , Fikriye Işıl ADIGÜZELa , Sadık KÜKRERa
aUniversity of Health Science Adana City Training and Research Hospital, Department of Gynecology and Obstetrics, Adana, Türkiye
JCOG. 2024;34(4):118-24
DOI: 10.5336/jcog.2024-102607
Article Language: EN
Copyright Ⓒ 2025 by Türkiye Klinikleri. This is an open access article under the CC BY-NC-ND license (
http://creativecommons.org/licenses/by-nc-nd/4.0/)
ABSTRACT
Objective: The aim of the study is to compare the plasma levels of SCUBE-1, a marker of vascular injury and endothelial dysfunction, between preeclamptic and normotensive pregnant women. Material and Methods: The current study was carried out at Health Sciences University Adana City Training and Research Hospital, implementing a prospective research design. The study included 46 pregnancies diagnosed with preeclampsia and an equal number of pregnancies with normal blood pressure, serving as control subjects. Hemoglobin, white blood cell, platelet, alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen, creatinine, spot urine protein creatinine ratio, and SCUBE1 values were analyzed between preeclampsia and control groups. Results: There were no statistically significant differences observed in age, gravidity, parity, or body mass index as demographic features among the groups. The mean SCUBE-1 values of preeclampsia and control group were 137.65±95.97 ng/mL and 69.45±44.35 ng/mL, respectively. A significant increase in the concentrations of SCUBE-1 levels was observed in pregnancies that presented with preeclampsia (p<0.001). There was a statistically significant difference between pregnant women with and without preeclampsia in terms of creatinine and blood urea nitrogen values of laboratory values (p<0.001). Conclusion: The potential of SCUBE-1 as a prognostic indicator for vascular damage in pregnancy is worth considering. Our research is the initial investigation to demonstrate elevated levels of SCUBE-1 in preeclampsia, indicating impaired function of the endothelial cells in the placenta.
REFERENCES:- Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466-80. [Crossref] [PubMed] [PMC]
- Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76(14):1690-702. [Crossref] [PubMed]
- Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol. 2011;31(1):33-46. [Crossref] [PubMed] [PMC]
- Roberts JM. Preeclampsia: what we know and what we do not know. Semin Perinatol. 2000;24(1):24-8. [Crossref] [PubMed]
- Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467-74. [Crossref] [PubMed] [PMC]
- Udenze I, Amadi C, Awolola N, Makwe CC. The role of cytokines as inflammatory mediators in preeclampsia. Pan Afr Med J. 2015;20:219. [PubMed] [PMC]
- Cornelius DC. Preeclampsia: from inflammation to immunoregulation. Clin Med Insights Blood Disord. 2018;11:1179545X17752325.. [Crossref] [PubMed] [PMC]
- Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol. 2007;2(3):543-9. [Crossref] [PubMed]
- Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005;46(6):1243-9. [Crossref] [PubMed]
- Tu CF, Yan YT, Wu SY, Djoko B, Tsai MT, Cheng CJ, et al. Domain and functional analysis of a novel platelet-endothelial cell surface protein, SCUBE1. J Biol Chem. 2008;283(18):12478-88. [Crossref] [PubMed]
- Xavier GM, Economou A, Senna Guimarães AL, Sharpe PT, Cobourne MT. Characterization of a mouse Scube3 reporter line. Genesis. 2010;48(12):684-92. [Crossref] [PubMed]
- Dai DF, Thajeb P, Tu CF, Chiang FT, Chen CH, Yang RB, et al. Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke. J Am Coll Cardiol. 2008;51(22):2173-80. [Crossref] [PubMed]
- Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003;69(1):1-7. [Crossref] [PubMed]
- Kunter V. Preeklampside signal peptid-CUB EGF domain-containing protein 1 (SCUBE-1) düzeyleri ve tanısal değeri [Tıpta uzmanlık tezi]. Ankara: Sağlık Bilimleri Üniversitesi; 2019. [Link]
- Bakris G, Ali W, Parati G. ACC/AHA versus ESC/ESH on hypertension guidelines: JACC guideline comparison. J Am Coll Cardiol. 2019;73(23):3018-26. [Crossref] [PubMed]
- ACOG Practice Bulletin No. 202: Gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):1. [PubMed]
- Haworth K, Smith F, Zoupa M, Seppala M, Sharpe PT, Cobourne MT. Expression of the Scube3 epidermal growth factor-related gene during early embryonic development in the mouse. Gene Expr Patterns. 2007;7(5):630-4. [Crossref] [PubMed]
- Aköz A, Türkdoğan KA, Kahraman Çetin N, Kum S, Duman A, Türe M, et al. Predicting critical duration and reversibility of damage in acute mesenteric ischemia: an experimental study. Ulus Travma Acil Cerrahi Derg. 2018;24(6):507-13. [Crossref] [PubMed]
- Turedi S, Tatli O, Alver A, Karaguzel E, Karaca Y, Turkmen S, et al. The diagnostic value of plasma SCUBE1, a novel biomarker of platelet activation, in testicular torsion: a randomized, controlled, experimental study. Urology. 2015;86(3):516-20. [Crossref] [PubMed]
- Xiao L, Wang M, Yang S, Li S, Huang Q, Xu L, et al. The diagnostic potential of plasma SCUBE-1 concentration for pulmonary embolism: a pilot study. Clin Respir J. 2023;17(4):263-9. [Crossref] [PubMed] [PMC]
- Katoh Y, Katoh M. Hedgehog signaling pathway and gastric cancer. Cancer Biol Ther. 2005;4(10):1050-4. [Crossref] [PubMed]
- Zhuang J, Deane JA, Yang RB, Li J, Ricardo SD. SCUBE1, a novel developmental gene involved in renal regeneration and repair. Nephrol Dial Transplant. 2010;25(5):1421-8. [Crossref] [PubMed]
- Yang RB, Ng CK, Wasserman SM, Colman SD, Shenoy S, Mehraban F, et al. Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. J Biol Chem. 2002;277(48):46364-73. [Crossref] [PubMed]
- Yang M, Guo M, Hu Y, Jiang Y. Scube regulates synovial angiogenesis-related signaling. Med Hypotheses. 2013;81(5):948-53. [Crossref] [PubMed]
- Gyselaers W. Preeclampsia is a syndrome with a cascade of pathophysiologic events. J Clin Med. 2020;9(7):2245. [Crossref] [PubMed] [PMC]
- Romero R, Chaiworapongsa T. Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state. J Clin Invest. 2013;123(7):2775-7. [Crossref] [PubMed] [PMC]
- Bayoglu Tekin Y, Baki Erin K, Yilmaz A. Evaluation of SCUBE-1 levels as a placental dysfunction marker at gestational diabetes mellitus. Gynecol Endocrinol. 2020;36(5):417-20. [Crossref] [PubMed]
- Erez O, Romero R, Jung E, Chaemsaithong P, Bosco M, Suksai M, et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol. 2022;226(2S):S786-S803. [Crossref] [PubMed] [PMC]
- Lin YC, Roffler SR, Yan YT, Yang RB. Disruption of Scube2 Impairs Endochondral Bone Formation. J Bone Miner Res. 2015;30(7):1255-67. [Crossref] [PubMed]
- Tu CF, Tsao KC, Lee SJ, Yang RB. SCUBE3 (signal peptide-CUB-EGF domain-containing protein 3) modulates fibroblast growth factor signaling during fast muscle development. J Biol Chem. 2014;289(27):18928-42. [Crossref] [PubMed] [PMC]
- Tsao KC, Tu CF, Lee SJ, Yang RB. Zebrafish scube1 (signal peptide-CUB (complement protein C1r/C1s, Uegf, and Bmp1)-EGF (epidermal growth factor) domain-containing protein 1) is involved in primitive hematopoiesis. J Biol Chem. 2013;288(7):5017-26. [Crossref] [PubMed] [PMC]
- Lindemann S, Gawaz M. SCUBE1--a new scoop in vascular biology? Cardiovasc Res. 2006;71(3):414-5. [Crossref] [PubMed]
- Tu CF, Su YH, Huang YN, Tsai MT, Li LT, Chen YL, et al. Localization and characterization of a novel secreted protein SCUBE1 in human platelets. Cardiovasc Res. 2006;71(3):486-95. [Crossref] [PubMed]
- Jian ZW, Zhang XM, Huang GS. Clinical value of the platelet and inflammatory factor activation in vascular endothelial injury in essential hypertension. Clin Hemorheol Microcirc. 2023;83(2):171-80. [Crossref] [PubMed]
- Guzel M, Dogru MT, Simsek V, Demir V, Alp C, Kandemir H, et al. Influence of circadian blood pressure alterations on serum SCUBE-1 and soluble CD40 ligand levels in patients with essential hypertension. Am J Cardiovasc Dis. 2019;9(4):42-8. [PubMed] [PMC]